Brind.

Financial analysts provided commentary on stock valuations and growth prospects for various companies, including Humana and Barclays.

1 report, 1 independent Updated Fri 00:00

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Baird Humana Barclays

Keep exploring

The entities involved

Baird
financial services provider
- Baird reaffirmed its Buy rating on MasTec stock on July 4, 2026.Sat 17:01
- Baird was one of the low bid bidders as the Pequot Lakes School District was mentioned in a council meeting.Thu 16:01
Humana
American managed health care company
- CMS rating changes affect major insurers like Humana, Centene, and Elevance, leading to legal challenges and financial adjustments.Mon 19:24
- Humana incorporated the ChemoFx Assay into its coverage policy.Mon 11:16
Barclays
British bank
- Barclays acted as the broker for Imperial Brands' share repurchase programme, with transactions conducted on the LSE starting May 28, 2026.13:57
- Barclays analysts initiated coverage on SpaceX and Palantir Technologies on October 13, 2026.11:28

Related events

UBS and Barclays shared common views on current market trends on August 30, 2026.Aug 30

Coverage

Newest first; wire copies grouped

Fri 00:00cnbc.com